Skip to main content
. 2018 Aug 6;10(2):352–357. doi: 10.1111/jdi.12894

Figure 2.

Figure 2

Glycemic variability over 24 h in patients during treatment with insulin glargine 300 U/mL or insulin degludec. Glucose levels were calculated from the flash glucose monitoring on the seventh measurement day. Dotted line, insulin glargine 300 U/mL; solid line, insulin degludec.